. Author manuscript; available in PMC: 2026 Jun 18.

Published in final edited form as: Patient Educ Couns. 2025 Oct 8;142:109382. doi: 10.1016/j.pec.2025.109382

Table 3:

Bivariable associations among HCP-related facilitators.

	PPR with PCP/WHP > 5 years^ю	Risk Discussion with PCP/WHP^∞	Seen a specialist^α
Risk Discussion with PCP/WHP^∞	X	X	9.88^*** (5.54, 17.6)
PPR with PCP/WHP > 5 years^ю	X	3.51^*** (2.27, 5.42)	2.04^*** (1.51, 2.75)
Race^±	.668^* (.488,.914)	.695^† (.471, 1.03)	.433^*** (.315,.596)
Known BRCA mutation^¥	1.48^* (1.02, 2.14)	41.7^***(5.78, 301.2)	16.0^***(9.15, 28.1)

Results are odds ratios (95 % confidence intervals in parentheses). Example interpretation: Black women were 2/3 as likely as White women to report having a PPR > 5 years.

p < 0.05.

^**

p < 0.01.

^***

p < 0.001.

^ю

Participants indicated how long their longest relationship was with a PCP/WHP; 0 = “≤ 5 years”, 1 = “> 5 years”.

^∞

Participants indicated whether they had ever discussed BC risk; 0 = ”Never”, 1 = ”A little” or “A lot”.

^α

Participants indicated whether they had ever seen a specialist about their BC risk; 0 = ”Never”, 1 = ”At least once”.

^±

Participants indicated whether they were non-Hispanic Black or non-Hispanic White= ; 0 = ”Non-Hispanic White”, 1 = ”Non-Hispanic Black”

^¥

Participants indicated whether they had ever received genetic testing and learned they had a BRCA mutation; 0 = ”No”, 1 = ”Yes”.